Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 4, 2009, Pages 337-345

  Shukla, Dali ^a   Chakraborty, Subhashis ^a   Singh, Sanjay ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bitter taste; Ion exchange resin; Orally disintegrating tablet; Resinate; Risperidone

Indexed keywords

ION EXCHANGE RESIN; POLACRILIN; RISPERDAL M TAB; RISPERIDONE; RISPERIDONE RESINATE; UNCLASSIFIED DRUG;

ARTICLE; BITTER TASTE; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; INFRARED SPECTROSCOPY; MASKING; ORALLY DISINTEGRATING TABLET; TABLET COMPRESSION; TABLET FORMULATION; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; COST-BENEFIT ANALYSIS; DRUG COMPOUNDING; DRUG STABILITY; ION EXCHANGE RESINS; RISPERIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; TASTE; X-RAY DIFFRACTION;

EID: 65349107998     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.337     Document Type: Article

References (30)

1. Mantell C. L., "Adsorption," 2nd ed., McGraw-Hill, New York, 1951, pp. 185-216.
2. Betty W. , Michael P. , Dokuzovic V. , Lam V. , U.S. Patent 6001392 (1999).
3. Agarwal R., Mittal R., Singh A., Drug Dev. Ind. Pharm., 26, 773- 776 (2000).
4. Jenke D. R., Pharm. Res., 6, 96-99 (1989).
5. Irwin W. J., Belaid K. A., Drug Dev. Ind. Pharm., 13, 2017-2031 (1987).
6. Burke G. M., Drug Dev. Ind. Pharm., 12, 713-732 (1986).
7. Plaizier-Vercammen J. A., Int. J. Pharm., 85, 45-50 (1992).
8. Anand V. , Kandarapu R., Garg S., Drug Dev. Technol., 6, 905-914 (2001).
9. Hui H., "Controlled Drug Delivery," ed. by Robinson J. R., Lee V. H. L., Marcel Dekker, New York, 1987, pp. 412-414.
10. Nanda A., Kandarapu R., Garg S., Indian J. Pharm. Sci., 64, 10-17 (2002).
11. Gao R., Shao Z. J., Fan A. C. L., Witchey-Lakshmanan L. C., Stewar D. C., U.S. Patent 6514492 (2003).
12. Honeysett R. A., Freely L. C., Hoadley T. H., Sims E. E., Eur. Pat. Appl. EP0501763 (1992).
13. Cotterill J. V. , Giovanna M., Cowan D. P. , Pest Manag. Sci., 62, 120- 125 (2006).
14. Manek S. P. , Kamat V. S., Indian J. Pharm. Sci., 43, 209-212 (1981).
15. Lu M. Y. , Borodkin S., Woodward L., Li P. , Diesner C., Hernandez L., Vadnere M., Pharm. Res., 8, 706-712 (1991).
16. Gole D., Savall T., Lyou-fu G., Dale W., Paul K., Davies J. D., U.S. Patent Application 20050036977 (2005).
17. Farag Y., Nairn J. G., J. Pharm. Sci, 77, 872-875 (1988).
18. Sanghavi N. M., Indian Drugs, 26, 27-32 (1988).
19. AMBERLITE™ IRP64, Pharmaceutical grade cation exchange resin: (http://www.rohmhaas.com/wcm/products/product-detail.page?product= 1120246&display-mode=tds&application=), Rohm and Haas website, 05 July 2008.
20. "European Pharmacopoeia," 4th ed., Supplement 4.2, Tablets, 2002, p. 2435.
21. Borodkin S., Yunker M. H., J. Pharm. Sci., 59, 481-486 (1970).
22. Saunders L., J. Pharm. Pharmacol., 5, 569-578 (1953).
23. Vyas A. H., Bhat C. V, Kamath B. R., Bafna S. L., J. Pharm. Sci, 62, 1386-1387 (1973).
24. Costa H. O., Neto O. M., Eckley C. A., Dysphagia, 20, 175-181 (2005).
25. Conaghey O. M., Cris J., Corrigan O. I., Int. J. Pharm., 170, 215-224 (1998).
26. Jasari T., Vuorio M., J. Controlled Release, 70, 219-229 (2001).
27. Herrera T., Matejka Z., Eliasek J., Desalination, 48, 161-169 (1983).
28. Liu Z., Cheung R., Wu Y. X., James R., J. Controlled Release, 77, 213-224 (2001).
29. Kankkunen T., Huupponen I., Lahtinen K., Sundell M., Ekman K., Kontturi K., Hirvonen J., Eur. J. Pharm. Sci., 16, 273-280 (2002).
30. Parakh S. R., Gothoskar A. V. , Pharm. Technol., 27, 92-100 (2003).